Scroll to top

Regulatory

CLINUVEL
Posted by CLINUVEL
February 11, 2021

SCENESSE® Granted Market Access In Israel

CLINUVEL today announced that SCENESSE® (afamelanotide 16mg) has been added to the...

Read More
CLINUVEL
Posted by CLINUVEL
October 27, 2020

Media Release – TGA approves Australian drug to protect patients from light and sun

New Australian-developed drug approved by TGA for metabolic disorder erythropoietic protoporphyria (EPP)...

Read More
CLINUVEL
Posted by CLINUVEL
October 27, 2020

Australian TGA approves SCENESSE®

Executive summary SCENESSE® approved by Australian TGA under Priority Review First approved...

Read More
We use cookies to give you the best experience.